OR Today Features AMDR’s Dan Vukelich

Practice Greenhealth Releases 2016 Sustainability Benchmark Report

Practice Greenhealth has announced the availability of its 2016 Sustainability Benchmark Report.

Report Highlights:

“Third-party reprocessing of certain FDA-approved single-use medical devices offers huge benefits to the hospital in driving down RMW tonnage and disposal fees while also dramatically reducing the up-front purchase cost for a reprocessed versus a virgin device (often by around 50 percent). It is important to note that there are two aspects to a reprocessing program—the collection of devices bound for reprocessing and the subsequent buy-back of the reprocessed devices. While the collection of devices for reprocessing can offer significant avoided waste tonnage, the bulk of the cost savings and environmental impact reduction is in the buy-back of reprocessed devices. Medical device reprocessing has continued to grow within Practice Greenhealth member hospitals as evidenced by the yearly savings and tonnage growth indicated…”

The report also notes that to maximize reprocessing savings, hospitals must remain vigilant in managing their program. 

”…Purchasing reprocessed devices also requires considerable negotiation with suppliers—some of whom insert carefully written contract requirements for a certain portion of virgin devices that must be purchased for every reprocessed device bought back. Knowledgeable buy-back can sometimes be a slower implementation process. ….Supply chain leadership is key in negotiating these contracts.”

Read More. (full access for Practice Greenhealth members)

Zion Research Report: Global Reprocessed Medical Devices Market Expected to Reach over $4bn by 2021




Source: Shawn Morgan, QWTJ LIVE

Zion Research has published a new report titled “Reprocessed Medical Devices Market (Cardiovascular Medical Devices, Laparoscopic Medical Devices, Orthopedic/ Arthroscopic Medical Devices Gastroenterology Medical Devices and General Surgery Medical Devices) for Hospital and Home Healthcare: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021”.According to the report, the global reprocessed medical devices market was valued at approximately USD 1.42 billion in 2015 and is expected to reach approximately USD 4.02 billion by 2021, growing at a CAGR of around 19.7% between 2016 and 2021…

The market is primarily driven by the increasing significance and need for medical waste disposal. Favorable government initiatives are another key driving factor for reprocessed medical device market.Moreover, the growing concern regarding high volume of waste and landfills generated globally is influential in shifting the focus towards reprocessing of medical devices. However, reluctance in adopting reprocessed medical devices may hamper the market growth within the forecast period. Nonetheless, reduced product pricing of reprocessed devices is anticipated to open up new growth opportunities in the near future…

Read More.

Request a Sample of the Report here.



AMDR Welcomes the Pan American Health Organization and INVIMA to Hygia

AMDR welcomes the Pan American Health Organization and INVIMA, the Colombian Medical Product competent authority to Hygia!






We look forward to cooperating as PAHO contemplates a comprehensive, Pan American medical device regulation that addresses medical device reprocessing.



Interview: Where Do New Reprocessing Rules Leave EU?





Questions over proper oversight and allowances for reprocessing of single-use devices in the EU caused significant debate among policymakers who developed the pending European Medical Devices Regulation. Reprocessing advocate Dan Vukelich talked to Medtech Insight about whether or not there will be an EU-wide approach to device reprocessing under the new rules, and more about the path forward for the practice.

“Frankly, as SUD remanufacturers now need to meet all the same MD requirements as any other manufacturer and await member states to affirmatively opt in, the standard for SUD remanufacturing is now higher than it is for most manufacturers…”

Read More.  (Subscription required)



Association Between Surgeon Scorecard Use and Lower Operating Room Costs

Source: HPN Online



Despite the significant contribution of surgical spending to healthcare costs, most surgeons are unaware of their operating room (OR) costs. A study published in JAMA Surgery looked at the association of costs in the operating room.

The study showed that providing cost scorecards to surgeons during 1 year, combined with a small financial departmental incentive and identification of physician cost-saving champions, was associated with a significant reduction in surgical supply costs compared with surgeons who did not receive scorecards but were still eligible for the same financial incentive.

Read More.



New Report: Global Reprocessed Medical Device Market Expected to Reach $4.95 Billion by 2021

Source: Ajay Daniel, WhaTech Channel, Medical Market Research


A new report from Research Nester Pvt Ltd finds that the “Reprocessed Medical Devices Market is one of the fast growing markets across the globe. There has been a [significant] rise in healthcare technology in the past few years to provide effective and affordable medical devices.”

The global reprocessed medical device market is expected to reach USD 4.95 Billion by 2021 from USD 0.76 Billion in 2013 and it is expected to grow at a CAGR of 19.55% over the forecast period i.e. 2015-2021. Increase in demand for reprocessed medical devices is expected to rise over the forecast period i.e. 2015-2021, driven by need to minimize the cost of clinical applications and diagnosis process to provide better and safe medical services.

Read More.

Request a Table of Contents for the Report



Good As New – Reprocessing Single-Use Devices

mdSource: Medical Device Developments

There are many challenges to pre-hospital sterilisation methods of medical equipment, from single-use disposable devices to longer-lasting equipment designed to work for years. Kerry Taylor-Smith explores the ongoing debate around reprocessing single-use devices. Association of Medical Device Reprocessors president Daniel Vukelich explains how single-use device reprocessing is a good way of containing costs without risking patient safety.

If a device is designed to be used just once, then that is the end of its life cycle. Or so one might think; in actual fact, many single-use devices (SUDs) are reprocessed and made safe for use again, and again, and again.

SUDs first appeared in the 1980s because of increasing concern regarding the safety of multiple-use devices in terms of infection risk. At the time, no one really thought about their impact on the environment, but with overflowing landfills and soaring costs of healthcare, repurposing them is now considered the responsible thing to do. Some SUDs really are designed for single use and are therefore disposed of; others are just labelled so by the original equipment manufacturer (OEM), leading some healthcare providers to believe that SUDs are only safe for one use. In fact, this is not always the case, and many SUDs can and are remanufactured either by the OEM or by third-party reprocessors. If a single-use instrument has been properly cleaned, tested and considered functional, repackaged and sterilised, then it can – and should – be reused…

Daniel Vukelich, president of the Association of Medical Device Reprocessors (AMDR) – which represents the legal and regulatory interests of third-party reprocessors of medical devices labelled for single use, and is dedicated to educating consumers and the healthcare community regarding the safety, legality, and benefits of third-party reprocessing – believes that sceptics are probably unaware of the realities.

“Ultimately, in our view, companies that are responsive to their healthcare providers’ needs are going to be successful in the long run. Hospitals cannot afford to throw away millions of dollars worth of recoverable devices every year – it is irresponsible and unsustainable. The marketplace is going to reward reprocessors that help hospitals and surgical centres to achieve their objectives,” argues Vukelich.

Read More.

Reprocessed Medical Devices Market Expected to Surpass $5 Billion by 2023

A new report by Global Market Insights forecasts that revenue from the reprocessed medical device market will increase by 20% CAGR by 2023, growing from $1.12 billion to over $5 billion.

“Based on the type of product, the global reprocessed medical devices market is divided into cardiovascular (blood pressure cuffs/tourniquet cuffs, electrophysiology cables, cardiac stabilization and positioning, diagnostic electrophysiology catheters and compression sleeves), gastroenterology, orthopedic/arthroscopic, laparoscopic, and general surgery equipment.

Laparoscopic equipment accounted for the second largest share as a consequence of rapidly increasing demand for minimally invasive techniques and is predicted to follow a similar trend in the coming years.  Hospitals account for nearly 40% of the revenue as owing to the increase in third party and in-house reprocessing caused by tremendous waste production. As per a report by the Association of Medical Device Reprocessors (AMDR), hospitals can save up to 50% of their equipment costs on using these aforementioned products.

To read more, or to request the Global Market Report, click here.




AMDR Presents at CleanMed Europe 2016

CleanMed Europe 2016 – Day 3 Round-Up



The final day of CleanMed Europe 2016 featured a wide range of parallel sessions where participants shared ideas and best practices on a wide range of topics including pharmaceutical management, waste management strategies and increasing education through leadership in the clinical environment.


Daniel Vukelich of the Association of Medical Device Reprocessors explains how members of the association validate their procedures so that devices are classed as “remanufactured” and have the same safety standards as the original equipment manufacturers.  With devices costing thousands of Euros increasingly being sold as “single use,” this service is increasingly important and can save significant amounts of money and waste.

Click here for the full roundup of CleanMed Day 3.

Thanks to everyone at CleanMed for making the event a success!


Celebrating Health Care Without Harm’s 20th Anniversary


Gary Cohen reflects on the last two decades in the environmental health movement and offers an opportunity for health care to redefine its role in the 21st century.

When we started Health Care Without Harm, we hardly knew anyone who worked in the health care sector. We were mostly outsiders, community activists who had been working for decades in the environmental movement. But we knew we needed powerful allies to transform this emerging science linking the environment to our health into action that would protect our children, our families, our communities. We needed health care.

Back then, new science revealed that low-dose exposures of toxic chemicals in the first thousand days of a child’s life could create a host of health problems later in life, including cancer, learning disabilities, infertility, and other chronic diseases. At the same time, we began to learn that pregnant women and unborn children were being exposed to these same toxic chemicals. We were outraged by this chemical trespass into our bodies. And so in September of 1996, a small group of individuals met at Commonweal in Bolinas, California, giving birth to Health Care Without Harm…

Read More.